Navigation Links
Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation
Date:6/18/2008

Case is first to show safety and effectiveness of using cloned cells alone

to kill tumors

SEATTLE, June 18 /PRNewswire/ -- Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission. A team led by Cassian Yee, M.D., an associate member of the Clinical Research Division at Fred Hutchinson Cancer Research Center, reports these findings in the June 19 issue of the New England Journal of Medicine.

Yee and colleagues removed CD4+ T cells, a type of white blood cell, from a 52-year-old man whose Stage 4 melanoma had spread to a groin lymph node and to a lung. T cells specific to targeting the melanoma were then expanded vastly in the laboratory using modifications to existing methods. The lab-grown cells were then infused into the patient with no additional pre- or post-conditioning therapies, such as growth-factor or cytokine treatment. Two months later, PET and CT scans revealed no tumors. The patient remained disease free two years later, when he was last checked.

"We were surprised by the anti-tumor effect of these CD4 T cells and its duration of response," Yee said. "For this patient we were successful, but we would need to confirm the effectiveness of therapy in a larger study."

Yee cautioned that these results, presented in the journal's "Brief Report" section, represent only one patient with a specific type of immune system whose tumor cells expressed a specific antigen. More studies are needed to confirm the effectiveness of the experimental T cell therapy. If proven successful in more patients, Yee predicted this therapy could be used for the 25 percent of all late-stage melanoma patients who have the same immune-system type and tumor antigen.

Using a patient's own immune system to combat cancer, called immunotherapy, is a growing area of research that aims to develop
'/>"/>

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. Many Heart Attack Patients Dont Get Best Emergency Treatment
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015  Desert Valley Medical Center, named a ... is the first U.S. hospital to deploy the wireless Leaf ... help reduce the duration of labor and risk of caesarian ... the risk of caesarean birth is reduced in mothers who ... mothers in labor are given epidurals and tend to lie ...
(Date:5/5/2015)... , May 05, 2015 Research and Markets ... the "Home Healthcare Global Market - Forecast to ... home healthcare market is expected to reach more than ... The home healthcare equipment market is expected ... healthcare services market. Home healthcare is gaining a tremendous ...
(Date:5/5/2015)... -- Lymphatic pump treatment (LPT) shows promise in managing ... new study published in The Journal of the ... LPT on infected rats three times a day followed ... treat pneumonia. After 96 hours, over 60 percent of ... percent of rats who received levofloxacin alone. ...
Breaking Medicine Technology:Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2Lymphatic Pump Treatment Enhances Antibiotic Effectiveness for Treating Pneumonia 2
... of the technology world moves to Basking Ridge, NJ when ... Trade-Investment Promotion Agency (KOTRA), kicks off later this month. The ... together companies seeking the most innovative and creative technology in ... at 8:30AM EDT (US & Canada) at the Dolce Hotels ...
... DURHAM, N.C., Oct. 18 Argos Therapeutics ... president and chief executive officer, will present an overview of ... EDT on Oct. 21 at the inaugural Cancer Immunotherapy Conference ... Ph.D ., the company,s chief scientific officer and vice president ...
Cached Medicine Technology:Top U.S. and Korean Companies to Converge at 2010 Global Partnering Day 2Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference 2
(Date:5/5/2015)... Fla. (PRWEB) May 05, 2015 Baptist ... the Commission on Cancer (CoC) of the American College ... cancer program must meet more than 30 Commission on ... through a survey process, and maintain levels of excellence ... , When patients choose to seek care locally at ...
(Date:5/5/2015)... Atlanta, Georgia (PRWEB) May 05, 2015 ... Software of Victoria BC announced the Skedans Sensor ... The platform, for mobile and web app developers, provides ... from airborne and mobile sensors. , The Skedans Sensor ... at the intersection of the Internet of Things, Web ...
(Date:5/5/2015)... May 05, 2015 MAP Health Management, ... revenue cycle management for addiction treatment facilities, announced today ... President of Business Development. Mr. Mooney, who has more ... field, will be responsible for developing new strategic partnerships ... MAP’s core products and new initiatives. , Prior to ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Okyanos, the ... Lifestyle Report today. The study was conducted to determine ... as osteoarthritis and sports-related injuries have had ... stiffness was the most prevalent symptom reported at 73%, ... as walking, standing and bending over. Over half of ...
(Date:5/5/2015)... On April 8th, 2015, at the ... Recovery sponsored Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, a daylong ... sustainable product placement in TV and film. , ... of ecologically sound and socially conscious products and services, ... that makes appearances at various awards ceremonies and festivals ...
Breaking Medicine News(10 mins):Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2
... against RSV, research shows , THURSDAY, Dec. 24 (HealthDay News) ... the ability to prevent infection with respiratory syncytial virus (RSV), ... can also be dangerous for adults with chronic lung diseases ... known as POPG, seems to help the lungs do a ...
... Dec. 24 Congressman Chaka Fattah (D-PA) releases the following ... legislation: , "Senate Democrats deserve our thanks and congratulations ... do, but I am confident that the House and the ... new year we will be sending President Obama a final ...
... improving legislation in conference committee , WASHINGTON, Jan. 24 ... this morning,s passage of the Patient Protection and Affordable Care ... and Senate to begin merging their respective bills and enact ... morning the Senate brought us closer to meaningful health care ...
... , WASHINGTON, Dec. 24 Today, The U.S. Conference of Mayors ... to provide health care for millions of the uninsured. In ... Senate passed the Patient Protection and Affordable Care Act. ... on legislation on Christmas Eve. It is appropriate the ...
... AARP Idaho Says Now Is the Time for State Congressional ... 24 Before the sun was up in Idaho ... costs received a glimmer of hope from Washington, D.C. With ... the Idaho congressional delegation can play a key role in making ...
... cells, study finds , THURSDAY, Dec. 24 (HealthDay News) -- ... cold and heal wounds, but the antioxidant might have another ... cells, new research suggests. , The findings, published online ... add to previous research that showed how adult cells can ...
Cached Medicine News:Health News:Discovery in Lungs May Lead to Treatment for Respiratory Virus 2Health News:AARP Thanks Senate for Passing Health Care Reform 2Health News:Health Care Reform Moves One Step Closer to Bringing Relief to Idaho Families 2
Intended for the quantitative determination of urea nitrogen in serum. Reaction: kinetic. Wavelength: 340 nm. Linearity: 150 mg/dL (53.4 mmol/L urea) at 37C....
For the quantitative determination of direct bilirubin in human serum. Linearity: 20 mg/dl...
For the quantitative determination of direct & total bilirubin in serum. Modified Malloy-Evelyn Diazotization Method. Endpoint Reaction Product measured at 540 nm. Linearity: 20 mg/dl...
... spectrophotometer designed specifically to run 24 hours ... rugged hardware, proven optical performance and a ... traditional spectrophotometry to obtain results quickly, accurately ... up to eight, 1 cm Biocell cuvettes ...
Medicine Products: